Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial

Gynecologic Oncology

Volumn 135, Issue 2, 2014, Pages 297-304

  Trabert, Britton ^a   Pinto, Ligia ^a,b   Hartge, Patricia ^a   Kemp, Troy ^b   Black, Amanda ^a   Sherman, Mark E ^a   Brinton, Louise A ^a   Pfeiffer, Ruth M ^a   Shiels, Meredith S ^a   Chaturvedi, Anil K ^a   Hildesheim, Allan ^a   Wentzensen, Nicolas ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Circulating inflammation markers; Cytokines; Inflammation; Nested case control study; Ovarian cancer; Pre diagnostic

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; IL1A PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; INTERLEUKIN 1ALPHA; TUMOR MARKER; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPOTHESIS; INFLAMMATION; LUNG CANCER; MAJOR CLINICAL STUDY; MIDDLE AGED; OVARY CANCER; OVARY FUNCTION; PROSTATE CANCER; BLOOD; EARLY CANCER DIAGNOSIS; IMMUNOLOGY; NEOPLASM; ODDS RATIO; OVARY TUMOR; RISK; STATISTICAL MODEL;

AGED; BIOMARKERS, TUMOR; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1ALPHA; INTERLEUKIN-8; LOGISTIC MODELS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; ODDS RATIO; OVARIAN NEOPLASMS; RISK; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84913610477     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.08.025     Document Type: Article

References (51)

1. Centers for Disease Control, Prevention Ovarian cancer statistics 2010 [Ref Type: Report]
2. R.B. Ness, and C. Cottreau Possible role of ovarian epithelial inflammation in ovarian cancer J Natl Cancer Inst 91 1999 1459 1467
3. B. Trabert, R.B. Ness, W.H. Lo-Ciganic, M.A. Murphy, E.L. Goode, and E.M. Poole Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium J Natl Cancer Inst 106 2014 djt431
4. R.J. Kurman, and I. Shih Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer - shifting the paradigm Hum Pathol 42 2011 918 931
5. M.A. McSorley, A.J. Alberg, D.S. Allen, N.E. Allen, L.A. Brinton, and J.F. Dorgan C-reactive protein concentrations and subsequent ovarian cancer risk Obstet Gynecol 109 2007 933 941
6. E. Lundin, L. Dossus, T. Clendenen, V. Krogh, K. Grankvist, and M. Wulff C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy) Cancer Causes Control 20 2009 1151 1159
7. E.M. Poole, I.M. Lee, P.M. Ridker, J.E. Buring, S.E. Hankinson, and S.S. Tworoger A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor alpha receptor 2 levels and risk of ovarian cancer Am J Epidemiol 178 2013 1256 1264
8. A.T. Toriola, K. Grankvist, C.B. Agborsangaya, A. Lukanova, M. Lehtinen, and H.M. Surcel Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study Ann Oncol 22 2011 1916 1921
9. N. Auersperg, M.I. Edelson, S.C. Mok, S.W. Johnson, and T.C. Hamilton The biology of ovarian cancer Semin Oncol 25 1998 281 304
10. H.J. Ziltener, S. Maines-Bandiera, J.W. Schrader, and N. Auersperg Secretion of bioactive interleukin-1, interleukin-6, and colony-stimulating factors by human ovarian surface epithelium Biol Reprod 49 1993 635 641
11. R.J. Norman, and M. Brannstrom Cytokines in the ovary: pathophysiology and potential for pharmacological intervention Pharmacol Ther 69 1996 219 236
12. L.L. Espey Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction Biol Reprod 50 1994 233 238
13. J.E. Wilson Adenocarcinomata in hens kept in a constant environment Poult Sci 37 1958 1253
14. A.K. Godwin, J.R. Testa, L.M. Handel, Z. Liu, L.A. Vanderveer, and P.A. Tracey Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer J Natl Cancer Inst 84 1992 592 601
15. P.C. Prorok, G.L. Andriole, R.S. Bresalier, S.S. Buys, D. Chia, and E.D. Crawford Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Control Clin Trials 21 2000 273S 309S
16. R.B. Hayes, A. Sigurdson, L. Moore, U. Peters, W.Y. Huang, and P. Pinsky Methods for etiologic and early marker investigations in the PLCO trial Mutat Res 592 2005 147 154
17. A.K. Chaturvedi, T.J. Kemp, R.M. Pfeiffer, A. Biancotto, M. Williams, and S. Munuo Evaluation of multiplexed cytokine and inflammation marker measurements: a methodologic study Cancer Epidemiol Biomarkers Prev 20 2011 1902 1911
18. W. Vongpatanasin, M. Tuncel, Z. Wang, D. Arbique, B. Mehrad, and I. Jialal Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women J Am Coll Cardiol 41 2003 1358 1363
19. A. Maccio, P. Lai, M.C. Santona, L. Pagliara, G.B. Melis, and G. Mantovani High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer Gynecol Oncol 69 1998 248 252
20. C.A. Blum, B. Muller, P. Huber, M. Kraenzlin, C. Schindler, and G.C. De Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight women J Clin Endocrinol Metab 90 2005 3230 3235
21. G. Capobianco, P. de Muro, G.M. Cherchi, M. Formato, A.J. Lepedda, and A. Cigliano Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles Arch Gynecol Obstet 282 2010 207 213
22. J.J. Puder, C.A. Blum, B. Mueller, G.C. De, L. Dye, and U. Keller Menstrual cycle symptoms are associated with changes in low-grade inflammation Eur J Clin Invest 36 2006 58 64
23. K. Wander, E. Brindle, and K.A. O'Connor C-reactive protein across the menstrual cycle Am J Phys Anthropol 136 2008 138 146
24. P.X. Bouckaert, J.L. Evers, W.H. Doesburg, L.A. Schellekens, P.H. Brombacher, and R. Rolland Patterns of changes in proteins in the peritoneal fluid of women during the periovulatory phase of the menstrual cycle J Reprod Fertil 77 1986 329 336
25. N. Mori, and D. Prager Transactivation of the interleukin-1alpha promoter by human T-cell leukemia virus type I and type II Tax proteins Blood 87 1996 3410 3417
26. P. Bhat-Nakshatri, T.R. Newton, R. Goulet Jr., and H. Nakshatri NF-kappaB activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1alpha Proc Natl Acad Sci U S A 95 1998 6971 6976
27. K.L. White, D.N. Rider, K.R. Kalli, K.L. Knutson, G.P. Jarvik, and E.L. Goode Genomics of the NF-kappaB signaling pathway: hypothesized role in ovarian cancer Cancer Causes Control 22 2011 785 801
28. F.R. Greten, M.C. Arkan, J. Bollrath, L.C. Hsu, J. Goode, and C. Miething NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta Cell 130 2007 918 931
29. B. Charbonneau, M.S. Block, W.R. Bamlet, R.A. Vierkant, K.R. Kalli, and Z. Fogarty Risk of ovarian cancer and the NF-kappaB pathway: genetic association with IL1A and TNFSF10 Cancer Res 74 2014 852 861
30. S. Hsu, M. Kim, L. Hernandez, V. Grajales, A. Noonan, and M. Anver IKK-epsilon coordinates invasion and metastasis of ovarian cancer Cancer Res 72 2012 5494 5504
31. R. Gonzalez-Ramos, S. Defrere, and L. Devoto Nuclear factor-kappaB: a main regulator of inflammation and cell survival in endometriosis pathophysiology Fertil Steril 98 2012 520 528
32. A. Yuan, J.J. Chen, P.L. Yao, and P.C. Yang The role of interleukin-8 in cancer cells and microenvironment interaction Front Biosci 10 2005 853 865
33. Y. Wang, R.C. Xu, X.L. Zhang, X.L. Niu, Y. Qu, and L.Z. Li Interleukin-8 secretion by ovarian cancer cells increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasion Cytokine 59 2012 145 155
34. K. Ivarsson, A. Ekerydh, I.M. Fyhr, P.O. Janson, and M. Brannstrom Upregulation of interleukin-8 and polarized epithelial expression of interleukin-8 receptor A in ovarian carcinomas Acta Obstet Gynecol Scand 79 2000 777 784
35. R.T. Penson, K. Kronish, Z. Duan, A.J. Feller, P. Stark, and S.E. Cook Cytokines IL-1beta, IL-12, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel Int J Gynecol Cancer 10 2000 33 41
36. A. Fasciani, G. D'Ambrogio, G. Bocci, S. Luisi, P.G. Artini, and A.R. Genazzani Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathology Fertil Steril 75 2001 1218 1221
37. S.K. Kassim, E.M. El-Salahy, S.T. Fayed, S.A. Helal, T. Helal, and E. Azzam Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients Clin Biochem 37 2004 363 369
38. A.E. Lokshin, M. Winans, D. Landsittel, A.M. Marrangoni, L. Velikokhatnaya, and F. Modugno Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer Gynecol Oncol 102 2006 244 251
39. M. Nowak, E. Glowacka, M. Szpakowski, K. Szyllo, A. Malinowski, and A. Kulig Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors Neuro Endocrinol Lett 31 2010 375 383
40. F. Balkwill Tumour necrosis factor and cancer Nat Rev Cancer 9 2009 361 371
41. Y. Wu, and B.P. Zhou TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion Br J Cancer 102 2010 639 644
42. T.C. Hsu, R. Nair, P. Tulsian, C.E. Camalier, G.A. Hegamyer, and M.R. Young Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation Cancer Res 61 2001 4160 4168
43. H. Kulbe, R. Thompson, J.L. Wilson, S. Robinson, T. Hagemann, and R. Fatah The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells Cancer Res 67 2007 585 592
44. M.M. Moradi, L.F. Carson, B. Weinberg, A.F. Haney, L.B. Twiggs, and S. Ramakrishnan Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer Cancer 72 1993 2433 2440
45. T.V. Clendenen, E. Lundin, A. Zeleniuch-Jacquotte, K.L. Koenig, F. Berrino, and A. Lukanova Circulating inflammation markers and risk of epithelial ovarian cancer Cancer Epidemiol Biomarkers Prev 20 2011 799 810
46. M.S. Shiels, R.M. Pfeiffer, A. Hildesheim, E.A. Engels, T.J. Kemp, and J.H. Park Circulating inflammation markers and prospective risk for lung cancer J Natl Cancer Inst 105 2013 1871 1880
47. D. Il'yasova, L.H. Colbert, T.B. Harris, A.B. Newman, D.C. Bauer, and S. Satterfield Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort Cancer Epidemiol Biomarkers Prev 14 2005 2413 2418
48. M.P. Purdue, Q. Lan, R. Bagni, W.G. Hocking, D. Baris, and D.J. Reding Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma Cancer Res 71 2011 4898 4907
49. R.J. Glynn, J.G. MacFadyen, and P.M. Ridker Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study Clin Chem 55 2009 305 312
50. T. Pischon, S.E. Hankinson, G.S. Hotamisligil, N. Rifai, and E.B. Rimm Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers Obes Res 11 2003 1055 1064
51. M.M. Epstein, E.C. Breen, L. Magpantay, R. Detels, L. Lepone, and S. Penugonda Temporal stability of serum concentrations of cytokines and soluble receptors measured across two years in low-risk HIV-seronegative men Cancer Epidemiol Biomarkers Prev 22 2013 2009 2015